Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study.
Tamás ResálPéter BacsurCsilla KeresztesAnita BálintRenáta BorAnna FábiánBernadett FarkasKostas KatsanosGeorge MichalopoylosDavide Giuseppe RibaldoneMohamed AttauabiMirabella ZhaoHadar Amir BarakHenit YanaiCristina BezzioAntonio RispoFabiana CastiglioneAriella Bar-Gil ShitritDaniela PuglieseAlessandro ArmuzziEdoardo Vincenzo SavarinoMartin KolarMilan LukášElena ChashkovaRafał FilipAurore RozieresStéphane NanceyŽeljko KrznarićEszter Schäfernull SzamosiPatrícia SarlósMatej FrankoDavid DrobneOleg V KnyazevAnna V KagramanovaJimmy LimdiPanu WetwittayakhlangPeter L LakatosNitsan MaharshakLian BannonTibor NyáriZoltán SzepesKlaudia Farkasnull nullTamás MolnárPublished in: Inflammatory bowel diseases (2023)
TFB is effective in both studied indications. TFB treatment resulted in high rates of SFR in the short and long terms. Higher baseline disease activity and previous biological therapies decreased efficacy. No new adverse event signals were found.